NexEos Bio today announced that Dawn Rubel has joined the Company as President, Research and Development.
PROPRIETARY ION SOURCE AND BEAM TECHNOLOGY CAPABLE OF PRODUCING APPROXIMATELY 10 TIMES THE CURRENT GLOBAL SUPPLY OF ASTATINE-211
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
Intermountain Health announced the launch of Culmination Bio, a biotech company developing an exclusive, anonymized, and de-identified intelligence platform.
BioUtah continues to monitor issues of importance to our industry and engage with legislators on Utah’s Capitol Hill.
R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals that Harm Environment
Facility will produce high-performance ceramic armor products for personnel, aircraft, and vehicles
SINTX Technologies Announces Closing of $12.0 Million Public Offering
US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System
Renalytix announces a c.$20.3 million private placement
NHP-specific ELISAs now available from Quansys Biosciences
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease